Shanghai Bio-heart Biological Technology Co., Ltd.

SEHK:2185 Stock Report

Market Cap: HK$433.3m

Shanghai Bio-heart Biological Technology Balance Sheet Health

Financial Health criteria checks 6/6

Shanghai Bio-heart Biological Technology has a total shareholder equity of CN¥745.5M and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥783.8M and CN¥38.3M respectively.

Key information

0%

Debt to equity ratio

CN¥0

Debt

Interest coverage ration/a
CashCN¥272.90m
EquityCN¥745.53m
Total liabilitiesCN¥38.28m
Total assetsCN¥783.82m

Recent financial health updates

Recent updates

We Think Shanghai Bio-heart Biological Technology (HKG:2185) Can Afford To Drive Business Growth

Nov 15
We Think Shanghai Bio-heart Biological Technology (HKG:2185) Can Afford To Drive Business Growth

Shanghai Bio-heart Biological Technology (HKG:2185) Is In A Good Position To Deliver On Growth Plans

Jul 24
Shanghai Bio-heart Biological Technology (HKG:2185) Is In A Good Position To Deliver On Growth Plans

Companies Like Shanghai Bio-heart Biological Technology (HKG:2185) Are In A Position To Invest In Growth

Feb 22
Companies Like Shanghai Bio-heart Biological Technology (HKG:2185) Are In A Position To Invest In Growth

Companies Like Shanghai Bio-heart Biological Technology (HKG:2185) Are In A Position To Invest In Growth

Nov 03
Companies Like Shanghai Bio-heart Biological Technology (HKG:2185) Are In A Position To Invest In Growth

We Think Shanghai Bio-heart Biological Technology (HKG:2185) Can Afford To Drive Business Growth

May 12
We Think Shanghai Bio-heart Biological Technology (HKG:2185) Can Afford To Drive Business Growth

We're Not Worried About Shanghai Bio-heart Biological Technology's (HKG:2185) Cash Burn

Sep 19
We're Not Worried About Shanghai Bio-heart Biological Technology's (HKG:2185) Cash Burn

Shanghai Bio-heart Biological Technology (HKG:2185) Is In A Good Position To Deliver On Growth Plans

Jun 03
Shanghai Bio-heart Biological Technology (HKG:2185) Is In A Good Position To Deliver On Growth Plans

Financial Position Analysis

Short Term Liabilities: 2185's short term assets (CN¥357.3M) exceed its short term liabilities (CN¥14.5M).

Long Term Liabilities: 2185's short term assets (CN¥357.3M) exceed its long term liabilities (CN¥23.8M).


Debt to Equity History and Analysis

Debt Level: 2185 is debt free.

Reducing Debt: 2185 has not had any debt for past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 2185 has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: 2185 has sufficient cash runway for 2.2 years if free cash flow continues to reduce at historical rates of 13.8% each year.


Discover healthy companies